Stop parsing PDFs. Get the API. Request Access
Hoth Therapeutics, Inc. Logo

Hoth Therapeutics, Inc.

A clinical-stage biopharma company advancing drugs for unmet medical needs.

HOTH | US

Overview

Corporate Details

ISIN(s):
US44148G2049
LEI:
Country:
United States of America
Address:
1177 AVENUE OF THE AMERICAS, 10036 NEW YORK
Website:
https://hoththerapeutics.com/
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company that acts as a catalyst in early-stage pharmaceutical research and development. The company focuses on advancing promising drug candidates from discovery through pre-clinical and clinical testing to address unmet medical needs. Its development pipeline includes innovative therapeutics for conditions such as skin disorders. Guided by a patient-centric mission to improve quality of life, Hoth Therapeutics also utilizes artificial intelligence to support its drug development programs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Hoth Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hoth Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Hoth Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
Anixa Biosciences Inc
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
Annovis Bio, Inc.
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
APPLIED DNA SCIENCES INC
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Aprea Therapeutics, Inc.
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
AprilBio Co.,Ltd.
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.